
Synaptrix Labs is dedicated to developing non-invasive brain-computer interfaces, particularly through their innovative product Neuralis, which aims to restore mobility and independence for individuals with severe neuromuscular conditions. Their technology leverages advanced neurotechnology and a powerful cloud compute architecture to translate user intentions into wheelchair maneuverability. Additionally, their Saffron-1 AI model enhances EEG signal detection and analysis, making it adaptable for various applications. With a strong multidisciplinary team and backing from renowned advisors, Synaptrix Labs is positioned to make significant advancements in assistive technology, focusing on accessibility and user-centric design.

Synaptrix Labs is dedicated to developing non-invasive brain-computer interfaces, particularly through their innovative product Neuralis, which aims to restore mobility and independence for individuals with severe neuromuscular conditions. Their technology leverages advanced neurotechnology and a powerful cloud compute architecture to translate user intentions into wheelchair maneuverability. Additionally, their Saffron-1 AI model enhances EEG signal detection and analysis, making it adaptable for various applications. With a strong multidisciplinary team and backing from renowned advisors, Synaptrix Labs is positioned to make significant advancements in assistive technology, focusing on accessibility and user-centric design.
Sector: AI-driven non-invasive brain–computer interfaces (BCI)
Flagship product: Neuralis (mind-controlled wheelchair)
Founded: 2023
HQ: New York, NY
Notable investor: Underdog Labs (recorded)
Assistive neurotechnology for paralysis and neurological conditions (EEG/EMG de-noising, assistive device control).
2023
Biotechnology Research
Public records indicate a Pre-Seed round recorded on this date with details obfuscated in the source.
“Underdog Labs recorded as an investor”
| Company |
|---|